Skip to main content
. 2011 Mar 15;20(Suppl 1):46–56. doi: 10.1007/s00586-011-1755-0

Table 4.

Clinical results combining VAS and Prolo evaluation at follow-up time

Combined results First follow-up examination Second follow-up examination
NR Prolo + NR VAS 6 (5.0%) 3 (2.6%)
NR Prolo + R VAS 10 (8.5%) 4 (3.5%)
R Prolo + NR VAS 2 (1.7%) 0 (0%)
R Prolo + R VAS 101 (84.8%) 109 (93.9%)

R responder, NR non-responder